Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. 4 Open-market buy Director bought 45,750 shares at an average $4.84 ($221,350)
  2. 4 Open-market buy Exec VP of Tech Operations bought 27,500 shares at an average $4.22 ($116,110)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy General Counsel bought 2,525 shares at $4.03 ($10,176)
  5. 4 Open-market buy Director bought 15,000 shares at $4.08 ($61,160)
  6. 4 Open-market buy Chief Executive Officer bought 4,830 shares at $4.14 ($19,985)
  7. 4 Open-market buy Director bought 5,000 shares at $3.95 ($19,750)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Director bought 10,000 shares at $3.85 ($38,500)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy General Counsel bought 3,250 shares at $3.05 ($9,913)
  16. 4 Open-market buy Chief Executive Officer bought 3,500 shares at $2.61 ($9,135)
  17. 4 Option exercise Director acquired 7,500 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 26 · 515 filings